Boothbay Fund Management LLC purchased a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) during the 3rd quarter, Holdings Channel reports. The institutional investor purchased 8,601 shares of the health services provider’s stock, valued at approximately $218,000.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Activest Wealth Management lifted its position in Teladoc Health by 270.5% during the 3rd quarter. Activest Wealth Management now owns 678 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 495 shares during the period. SeaCrest Wealth Management LLC purchased a new stake in shares of Teladoc Health in the second quarter worth $28,000. Quadrant Capital Group LLC grew its stake in shares of Teladoc Health by 23.3% in the second quarter. Quadrant Capital Group LLC now owns 1,385 shares of the health services provider’s stock worth $46,000 after acquiring an additional 262 shares during the last quarter. Wahed Invest LLC purchased a new stake in shares of Teladoc Health in the second quarter worth $49,000. Finally, Avondale Wealth Management purchased a new stake in shares of Teladoc Health in the third quarter worth $51,000. Hedge funds and other institutional investors own 84.14% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on TDOC. StockNews.com raised Teladoc Health to a “sell” rating in a research note on Friday, February 24th. Barclays cut their target price on Teladoc Health from $32.00 to $28.00 and set an “equal weight” rating on the stock in a research note on Wednesday, January 18th. JPMorgan Chase & Co. cut their target price on Teladoc Health from $35.00 to $33.00 and set a “neutral” rating on the stock in a research note on Monday, February 27th. Oppenheimer cut their target price on Teladoc Health from $37.00 to $35.00 and set an “outperform” rating on the stock in a research note on Thursday, February 23rd. Finally, Citigroup dropped their price objective on Teladoc Health from $33.00 to $30.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 28th. One investment analyst has rated the stock with a sell rating, nineteen have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $36.96.
Insider Transactions at Teladoc Health
Teladoc Health Price Performance
Shares of NYSE:TDOC opened at $26.88 on Monday. The stock’s 50-day simple moving average is $27.22 and its two-hundred day simple moving average is $27.99. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.29 and a quick ratio of 3.15. Teladoc Health, Inc. has a 52-week low of $21.60 and a 52-week high of $77.50.
Teladoc Health (NYSE:TDOC – Get Rating) last posted its quarterly earnings data on Wednesday, February 22nd. The health services provider reported ($0.23) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.04. Teladoc Health had a negative return on equity of 4.35% and a negative net margin of 567.53%. The firm had revenue of $637.71 million for the quarter, compared to the consensus estimate of $633.71 million. As a group, equities analysts forecast that Teladoc Health, Inc. will post -1.41 earnings per share for the current year.
Teladoc Health Company Profile
Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Get Rating).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.